| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07575399 Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor… |
Recruitment opened |
| 2026-06-12 | NCT07575399 Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor… |
Trial sites expanded: 0 -> 40 locations |
| 2026-06-05 | NCT07226765 Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea… |
Trial sites expanded: 49 -> 53 locations |
| 2026-05-30 | NCT07037433 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in… |
Trial sites expanded: 769 -> 772 locations |
| 2026-05-23 | NCT07225686 Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea… |
Trial sites expanded: 53 -> 56 locations |
| 2026-05-23 | NCT07037433 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in… |
Trial sites expanded: 766 -> 769 locations |
| 2026-05-23 | NCT07441252 A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With… |
Trial sites expanded: 18 -> 21 locations |
| 2026-05-23 | NCT07226765 Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea… |
Trial sites expanded: 46 -> 49 locations |
| 2026-05-15 | NCT07226765 Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea… |
Trial sites expanded: 42 -> 46 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07037459 | Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection… | Heart Failure With Preserved Ejection Fraction | Recruiting |
| NCT07225686 | Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea… | Obesity | Recruiting |
| NCT07037433 | Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in… | Atherosclerotic Cardiovascular Disease | Recruiting |
| NCT07226765 | Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea… | Obstructive Sleep Apnea | Recruiting |
| NCT07575399 | Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor… | Obesity or Overweight | Recruiting |
| NCT06858878 | Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes… | Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight | Active, Not Recruiting |
| Phase 2 | |||
| NCT07441252 | A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With… | Overweight or Obesity and Elevated Liver Fat | Recruiting |
| Phase 1 | |||
| NCT07523711 | Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed… | Overweight | Recruiting |
| NCT07160257 | A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and… | Type 2 Diabetes Mellitus | Recruiting |
| NCT07229157 | Effect of Maridebart Cafraglutide on the Heart's Electrical Activity | Overweight | Active, Not Recruiting |
| NCT07226778 | Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the… | Overweight | Active, Not Recruiting |
| NCT07313761 | A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made… | Overweight and Obesity | Active, Not Recruiting |